Adagene

Performance

About Adagene

Adagene is a Nasdaq-listed global clinical-stage biotech company specializing in immunotherapy and the discovery and design of antibodies for cancer treatment. The company leverages a dynamic, multi-purpose antibody platform to identify candidates with novel mechanisms of action and to advance a pipeline of cancer therapies. With a focus on precision engineering and understanding protein folding and molecular motion, Adagene aims to redefine antibody discovery and development on a global scale.